Alternatives to standard blood transfusion: availability and promise (Q33785932)

29 July 2017

1 reference

title

Alternatives to standard blood transfusion: availability and promise (English)

1 reference

29 July 2017

Prowse CV

1

1 reference

29 July 2017

publication date

1 December 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

9

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

287-299

1 reference

Dendritic cells: therapeutic potentials

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Choice of human plasma preparations for transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Activation and adherence of lyophilized human platelets on canine vessel strips in the Baumgartner perfusion chamber

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Gene and cell transfer for specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Sheep cloned by nuclear transfer from a cultured cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Human albumin administration in critically ill patients: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Economic evaluations of technologies to minimize perioperative transfusion: a systematic review of published studies. International Study of Peri-operative Transfusion (ISPOT) investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Transfusion medicine. First of two parts--blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

A phase I/IIA clinical study with a chimeric mouse-human monoclonal antibody to the V3 loop of human immunodeficiency virus type 1 gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Cytokines to reduce platelet transfusions: non-TPO cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Making Landsteiner's discovery superfluous: safety and economic implications of a universal group O red blood cell supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Platelet growth factors: potential impact on transfusion medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

AAVant-garde gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Leucodepletion of blood products by filtration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Humoral regulation of hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Prevention of transfusion-transmitted cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Gene transfer into human haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Ex vivo expansion of cord blood progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Hematopoietic stem cell expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

EBV specific CTL: a model for immune therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

A history of haemopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

Preservation of red cell properties after virucidal phototreatment with dimethylmethylene blue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.1999.00212.X

10.1046/J.1365-3148.1999.00212.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference